CVS Health Receivables 2010-2024 | CVS
CVS Health receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
- CVS Health receivables for the quarter ending September 30, 2024 were $36.179B, a 9.88% increase year-over-year.
- CVS Health receivables for 2023 were $35.227B, a 29.15% increase from 2022.
- CVS Health receivables for 2022 were $27.276B, a 11.65% increase from 2021.
- CVS Health receivables for 2021 were $24.431B, a 12.37% increase from 2020.
CVS Health Annual Receivables
(Millions of US $) |
| 2023 |
$35,227 |
| 2022 |
$27,276 |
| 2021 |
$24,431 |
| 2020 |
$21,742 |
| 2019 |
$19,617 |
| 2018 |
$17,631 |
| 2017 |
$13,181 |
| 2016 |
$12,164 |
| 2015 |
$11,888 |
| 2014 |
$9,687 |
| 2013 |
$8,729 |
| 2012 |
$6,479 |
| 2011 |
$6,047 |
| 2010 |
$4,925 |
| 2009 |
$5,457 |
CVS Health Quarterly Receivables
(Millions of US $) |
| 2024-09-30 |
$36,179 |
| 2024-06-30 |
$32,385 |
| 2024-03-31 |
$32,217 |
| 2023-12-31 |
$35,227 |
| 2023-09-30 |
$32,927 |
| 2023-06-30 |
$29,546 |
| 2023-03-31 |
$28,331 |
| 2022-12-31 |
$27,276 |
| 2022-09-30 |
$26,317 |
| 2022-06-30 |
$27,233 |
| 2022-03-31 |
$26,451 |
| 2021-12-31 |
$24,431 |
| 2021-09-30 |
$25,283 |
| 2021-06-30 |
$24,164 |
| 2021-03-31 |
$23,855 |
| 2020-12-31 |
$21,742 |
| 2020-09-30 |
$23,816 |
| 2020-06-30 |
$22,520 |
| 2020-03-31 |
$23,037 |
| 2019-12-31 |
$19,617 |
| 2019-09-30 |
$19,789 |
| 2019-06-30 |
$18,174 |
| 2019-03-31 |
$19,509 |
| 2018-12-31 |
$17,631 |
| 2018-09-30 |
$14,837 |
| 2018-06-30 |
$14,158 |
| 2018-03-31 |
$13,964 |
| 2017-12-31 |
$13,181 |
| 2017-09-30 |
$12,440 |
| 2017-06-30 |
$12,274 |
| 2017-03-31 |
$12,114 |
| 2016-12-31 |
$12,164 |
| 2016-09-30 |
$13,625 |
| 2016-06-30 |
$13,183 |
| 2016-03-31 |
$13,025 |
| 2015-12-31 |
$11,888 |
| 2015-09-30 |
$12,804 |
| 2015-06-30 |
$10,892 |
| 2015-03-31 |
$10,162 |
| 2014-12-31 |
$9,687 |
| 2014-09-30 |
$10,828 |
| 2014-06-30 |
$9,533 |
| 2014-03-31 |
$9,086 |
| 2013-12-31 |
$8,729 |
| 2013-09-30 |
$8,035 |
| 2013-06-30 |
$7,093 |
| 2013-03-31 |
$6,635 |
| 2012-12-31 |
$6,479 |
| 2012-09-30 |
$6,407 |
| 2012-06-30 |
$6,124 |
| 2012-03-31 |
$6,109 |
| 2011-12-31 |
$6,047 |
| 2011-09-30 |
$5,901 |
| 2011-06-30 |
$5,892 |
| 2011-03-31 |
$5,348 |
| 2010-12-31 |
$4,925 |
| 2010-09-30 |
$5,111 |
| 2010-06-30 |
$5,101 |
| 2010-03-31 |
$5,149 |
| 2009-12-31 |
$5,457 |
| 2009-09-30 |
$5,693 |
| 2009-06-30 |
$5,520 |
| 2009-03-31 |
$5,358 |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$70.181B |
$357.776B |
|
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
|
